Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia
Transfusion · 2026-05 · 66 (5) · 941-951
DOI: 10.1111/trf.70147 ↗At a glance
Kohortenstudie in Transfusion, published online on 2026-03-06. Written by Surendra Karki and 4 co-authors. Institution: Strategy and Research, Australian Red Cross Lifeblood, Sydney, New South Wales, Australia. Major MEDLINE topics: ABO Blood-Group System, Coronary Disease, Blood Donors. 40 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
ABO blood groups may be associated with increased risk for several diseases including cardiovascular diseases (CVDs), particularly coronary heart disease (CHD). The role of other significant blood group systems, such as RhD and RhCE, has not been extensively investigated.
Methods
We linked The Sax Institute's 45 and Up Study to blood donation records and other health data to examine the association between ABO and Rh blood groups with CVD, CHD, and Cerebrovascular disease (CeVD). We used ICD10 codes from hospital admission data to ascertain the study outcomes. Cox‐proportional hazards regression models were performed to assess the association.
Results
A total of 32,510 blood donors were included. Over an average follow‐up period of just over 10 years, 8.3%, 5.4%, and 2.3% developed CVD, CHD, and CeVD, respectively. CHD incidence was highest among individuals with group AB (6.6/1000 person‐years). Compared to group O, fully adjusted hazard ratios for CHD were: A, 1.05 (95% confidence intervals [CI]: 0.95–1.16); B, 0.99 (0.84–1.16); AB, 1.27 (1.01–1.59). RhD or RhCE blood groups were not associated with CHD. For CeVD, 738 cases (2.3%) occurred, with no evidence of associations found for ABO, RhD, or RhCE blood groups. No significant association was observed between ABO blood group and all CVDs considered together as an outcome.
Conclusion
There was a borderline association of higher CHD risk in individuals with blood group AB compared with group O, whereas no association was observed for groups A or B individually.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Strategy and Research, Australian Red Cross Lifeblood, Sydney, New South Wales, Australia.
- School of Population Health, University of New South Wales, Sydney, New South Wales, Australia.
- School of Public Health, University of Technology, Sydney, New South Wales, Australia.
- Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
- Faculty of Health, University of Canberra, Canberra, Australian Capital Territory, Australia.
- School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia.
ORCID profiles: Rena Hirani
Cite
APA
Karki, S., Bell, K., Irving, D. O., Welvaert, M., & Hirani, R. (2026). Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia. Transfusion, 66(5), 941-951. https://doi.org/10.1111/trf.70147
Vancouver
Karki S, Bell K, Irving DO, Welvaert M, Hirani R. Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia. Transfusion. 2026;66(5):941-951. doi:10.1111/trf.70147
BibTeX
@article{Karki2026,
author = {Karki, Surendra and Bell, Katy and Irving, David O and Welvaert, Marijke and Hirani, Rena},
title = {Association of ABO blood group and coronary heart disease in blood donors—Results from a cohort study in Australia},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {5},
pages = {941--951},
doi = {10.1111/trf.70147}
}
EUVIMED